Literature DB >> 16928997

Dystonia.

Daniel Tarsy1, David K Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16928997     DOI： 10.1056/NEJMra055549

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  65 in total

1.  Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Authors:  Stanley N Caroff; Irene Hurford; Janice Lybrand; E Cabrina Campbell
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

2.  Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study.

Authors:  Sebastian Paus; Jennifer Gross; Martina Moll-Müller; Frank Hentschel; Annika Spottke; Bettina Wabbels; Thomas Klockgether; Michael Abele
Journal:  J Neurol       Date:  2011-04-16       Impact factor: 4.849

Review 3.  Designing clinical trials for dystonia.

Authors:  Wendy R Galpern; Christopher S Coffey; Alberto Albanese; Ken Cheung; Cynthia L Comella; Dixie J Ecklund; Stanley Fahn; Joseph Jankovic; Karl Kieburtz; Anthony E Lang; Michael P McDermott; Jeremy M Shefner; Jan K Teller; John L P Thompson; Sharon D Yeatts; H A Jinnah
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

4.  Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.

Authors:  Thomas M Bridges; Ashley E Brady; J Phillip Kennedy; R Nathan Daniels; Nicole R Miller; Kwango Kim; Micah L Breininger; Patrick R Gentry; John T Brogan; Carrie K Jones; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2008-09-10       Impact factor: 2.823

Review 5.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

6.  Extreme task specificity in writer's cramp.

Authors:  Ejaz A Shamim; Jason Chu; Linda H Scheider; Joseph Savitt; H A Jinnah; Mark Hallett
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

7.  The basal ganglia and cerebellum interact in the expression of dystonic movement.

Authors:  Vladimir K Neychev; Xueliang Fan; V I Mitev; Ellen J Hess; H A Jinnah
Journal:  Brain       Date:  2008-07-26       Impact factor: 13.501

8.  Botulinum toxin type A therapy for blepharospasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Raquel E Marques; Mafalda Castelão; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

9.  Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.

Authors:  Nicole R Miller; R Nathan Daniels; Thomas M Bridges; Ashley E Brady; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2008-09-11       Impact factor: 2.823

10.  The intermuscular 3-7 Hz drive is not affected by distal proprioceptive input in myoclonus-dystonia.

Authors:  J N van der Meer; A C Schouten; L J Bour; E de Vlugt; A F van Rootselaar; F C T van der Helm; M A J Tijssen
Journal:  Exp Brain Res       Date:  2010-02-16       Impact factor: 1.972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.